In summary, our study successfully identified CDKN1A, a key protein associated with ferroptosis, senescence, and the cell cycle, and highlighted its potential as a therapeutic target for Eltrombopag in the treatment of ITP. The gene discussed is CDKN1A; the disease is autoimmune thrombocytopenic purpura.